Neuralink’s N1 chip is evolving rapidly. Featuring 1,024 electrodes across 64 threads, this tech is revolutionizing human-machine integration.

After successful human trials, engineers have perfected insertion techniques for long-term stability. While competitors like Synchron push boundaries, Neuralink’s FDA Breakthrough status signals a massive shift toward commercial scalability.

The future of thought-controlled computing is officially here, bridging biological intent with digital reality.